Embracing Future Holdings Limited (SGX:8YY)

Market Cap	62.40M
Revenue (ttm)	2.49M
Net Income (ttm)	-2.61M
Shares Out	1.73B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,741,900
Average Volume	14,892,470
Open	0.0360
Previous Close	0.0370
Day's Range	0.0360 - 0.0380
52-Week Range	0.0160 - 0.0400
Beta	0.24
RSI	62.08
Earnings Date	Oct 31, 2025

About Embracing Future Holdings

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 b...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2009
• Employees: 7
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 8YY

Financial Performance

In 2024, Embracing Future Holdings's revenue was 858,000, an increase of 176.77% compared to the previous year's 310,000. Losses were -3.43 million, 38.0% more than in 2023.